Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
Top Cited Papers
Open Access
- 1 May 2023
- journal article
- letter
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 30 (5) , 558-586
Abstract
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.Keywords
This publication has 115 references indexed in Scilit:
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering TherapyCirculation, 2011
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.BMJ, 1992
- The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemiaJournal of Internal Medicine, 1990
- Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levelsJournal of Internal Medicine, 1990
- Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnoverThe Journal of Pediatrics, 1988
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- Coronary artery disease in heterozygous familial hypercholesterolemiaAtherosclerosis, 1982
- PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1975
- Pseudohomozygous type II hyperlipoproteinemiaThe Journal of Pediatrics, 1974